AAE Online CE
Contemporary Issues in Dental Pharmacology
CE Hours: 1.5
Antibiotic therapy in endodontics can be based upon empirical prescribing decisions utilizing guidance promulgated by professional organizations, although emerging trends in antibiotic resistance patterns and systemic complications may compel modifications to these regimens. Similarly, the management of acute pain and anxiety continues to employ traditional NSAIDs, opioids and benzodiazepines, although newer information on the pharmacogenomics and pharmacokinetics of these drugs, as well as recent trends in substance abuse and diversion, may alter their prescribing patterns. Professional guidelines for patients taking antiresorptive therapy are available, although new scientific evidence will inevitably dictate refinement and modification of strategies employed in the dental management of these cases.
At the conclusion, participants should be able to:
- Describe the pharmacologic characteristics of antibiotics-of-choice for odontogenic infections and the appropriate and inappropriate uses of antibiotics, including considerations for antibiotic prophylaxis
- Describe the potential adverse interactions of specific analgesic and sedative medications prescribed in endodontics and the pharmacogenomic and pharmacokinetic factors which affect their safety and efficacy
- Summarize current professional guidelines for the dental management of patients taking antiresorptive drugs
|Access Date||Quiz Result||Score||Actions|
Arthur H. Jeske, Ph.D., D.M.D.
Dr. Jeske is Associate Dean and Professor, Department of General Practice and Dental Public Health, University of Texas School of Dentistry, where he teaches local anesthesia and pharmacology. He earned his Ph.D. and D.M.D. degrees from the Medical College of Georgia. He is a member of the Greater Houston Dental Society, Texas Dental Association, and the American Dental Association (ADA). He is past editor of the Journal of the Greater Houston Dental Society and the Texas Dental Journal and is currently Editor-in-Chief of Mosby's Dental Drug Reference. He is a past member and Chair of the ADA Council on Scientific Affairs, has served on several ADA National Board Test Construction committees and is a contributor to the ADA Center for Evidence-Based Dentistry. Dr. Jeske is a Life Member of Omicron Kappa Upsilon and is Fellow in the American College of Dentists, the International College of Dentists and the Academy of Dentistry International. He practices general dentistry in Houston, Texas.
Arthur Jeske, Ph.D., D.M.D.
In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated below:
financial relationships: Elsevier Publishing (Other Financial or Material Support, Textbook Editor)